Table 3 Germline CDH1 variants identified in the 243-case Japanse and trans-ethnic GCs in a recent report
From: Lifestyles, genetics, and future perspectives on gastric cancer in east Asian populations
CDH1 variants | Exon | Domain | HDGCa | ClinVar | Polyphen2 (HumDiv) | Japanese 243 GCsb | Korean populationc | TCGA non-Asian 212 GCs | Japanese 105 DGCs | TCGA non-Asian 62 DGCs | DGC: Japanese vs. non-Asian | Japanese ToMMo 1070 individuals | Japanese DGC vs. ToMMo | 1000 Genomes EAS 504 individuals | 1000 Genomes EUR 503 individuals | 1000 Genome EAS vs. EUR | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Age | Lauren’s classification | Family history of cancers | Age | Lauren’s classification | ||||||||||||||||
p.G62V | Exon 3 | Precursor region | ◯ | Ref. # [83] | Uncertain significance | Probably damaging | 80s | IGC | Yes | 1 | 3 | |||||||||
60s | DGC | No | ||||||||||||||||||
p.K182N | Exon 5 | Extracellular domain | ◯ | Ref. # [89] | Conflicting interpretations of pathogenicity | benign | 30s | DGC | 1 | 1 | ||||||||||
40s | DGC | |||||||||||||||||||
50s | DGC | |||||||||||||||||||
p.S270A | Exon 6 | Extracellular domain | Conflicting interpretations of pathogenicity | benign | 1 | |||||||||||||||
p.T340A | Exon 8 | Extracellular domain | ◯ | Benign | benign | 80s | DGC | Yes | 2 | 6 | 1 | |||||||||
60s | DGC | No | ||||||||||||||||||
30s | DGC | |||||||||||||||||||
p.T529A | Exon 11 | Extracellular domain | ◯ | Ref. # [89] | Conflicting interpretations of pathogenicity | benign | 30s | DGC | ||||||||||||
p.A592T | Exon 12 | Extracellular domain | Benign | Probably damaging | 5 | 1 | 2 | |||||||||||||
p.L630V | Exon 12 | Extracellular domain | Benign | Probably damaging | 70s | DGC | Yes | 4 | 9 | 6 | ||||||||||
70s | DGC | No | ||||||||||||||||||
80s | IGC | Yes | ||||||||||||||||||
60s | DGC | No | ||||||||||||||||||
80s | DGC | Yes | ||||||||||||||||||
60s | IGC | Yes # | ||||||||||||||||||
60s | DGC | |||||||||||||||||||
p.D777N | Exon 15 | Cytoplasmic domain | Conflicting interpretations of pathogenicity | Probably damaging | 1 | |||||||||||||||
p.V832M | Exon 16 | Cytoplasmic domain | ◯ | Benign | Probably damaging | 90s | DGC | No | 6 | 10 | 2 | |||||||||
50s | DGC | Yes | ||||||||||||||||||
50s | DGC | Yes | ||||||||||||||||||
60s | IGC | No | ||||||||||||||||||
60s | DGC | No | ||||||||||||||||||
50s | DGC | Yes # | ||||||||||||||||||
60s | DGC | Yes | ||||||||||||||||||
70s | IGC | |||||||||||||||||||
p.K870R | Exon 16 | Cytoplasmic domain | Not found | benign | 1 | 1 | ||||||||||||||
p.E880K | Exon 16 | Cytoplasmic domain | ◯ | Ref. # [89] | Conflicting interpretations of pathogenicity | Probably damaging | 30s | DGC | Yes | 1 | 7 | 2 | ||||||||
30s | DGC | |||||||||||||||||||
30s | DGC | |||||||||||||||||||
18 (7.41%) | 8 (3.77%) | 14 (13.33%) | 2 (3.23%) | 4.13-fold | 36 (3.36%) | 3.96-fold | 12 (2.38%) | 2 (0.40%) | 5.99-fold | |||||||||||